TCT 2026
Complexity is inevitable. Certainty is essential.

Join Abbott at TCT 2026

October 31 – November 3, 2026
San Diego Convention Center | San Diego, CA

Explore our TCT program

Saturday, October 31

Featured Clinical Research: Structural Heart

Amplatzer™ Valvular Plug III for PVL closure after surgical aortic or mitral valve replacement: primary results from the PARADIGM study

Date: Saturday, October 31

Time: 9:00–9:15AM PST

Location: World Connect Theater

Featured Expert: Dr. Amar Krishnaswamy

Add to calendar

Amplatzer™ Valvular Plug III is neither approved nor available for sale in the U.S.

Dr. Amar Krishnaswamy

Sunday, November 1

Visit Abbott in the Exhibit Hall to experience Abbott innovations through:

  • Live product demonstrations
  • Interactive hands-on learning opportunities
  • Case-based discussions with experts
  • Technology showcase across cardiovascular portfolio
  • Opportunities to connect with Abbott Product Experts

Abbott Booth # 4337


Featured Clinical Research: Structural Heart

A novel balloon-expandable transcatheter heart valve for aortic stenosis: the BE TAVI early feasibility study (Abbott BE)

Date: Sunday, November 1

Time: 11:13–11:27AM PST

Location: Innovation Theater

Featured Expert: Dr. Susheel Kodali

Add to calendar

CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only.

Dr. Susheel Kodali

Featured Clinical Research: Vascular

SonicForce™ Intravascular Lithotripsy in severe calcific CAD: primary results from the TECTONIC CAD IVL IDE Study

Presented within Calcium management: new devices and new data from key clinical trials

Date: Sunday, November 1

Presentation Time: 12:44–12:52PM PST

Q&A: 12:52–12:58PM PST

Location: Coronary Live Case Theater

Presenter: Dr. Eric Secemsky

Add to calendar

CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and is not commercially available.

Dr. Eric Secemsky
Presenter

Scientific Abstracts: Structural Heart

Impact of procedural volume on 30-day outcomes following T-TEER with the TriClip™ System: findings from the STS/ACC TVT Registry

Date: Sunday, November 1

Time: 12:30–12:40PM PST

Location: Abstract Station 8

Featured Expert: Dr. Brian Whisenant

Dr. Brian Whisenant

Scientific Abstracts: Structural Heart

One-year outcomes from the Amplatzer™ Talisman™ PFO Post-Approval Study

PFO Post-Approval Study presentation of 1-year data

Date: Sunday, November 1

Time: 12:30–12:40PM PST

Location: Abstract Station 10

Featured Expert: Dr. Barry Love

Dr. Barry Love

Symposium: Structural Heart

Contemporary considerations for TAVI: coronary access, durability and future reinterventions

Date: Sunday, November 1

Time: 12:30–1:45PM PST

Location: Coronary Arena

Moderator: Dr. Bassem Chehab

Featured Experts: Dr. Azeem Latib, Dr. Matthew Summers, Dr. Stephen Worthley, Dr. Luca Testa, Dr. Amber Makani

Dr. Bassem Chehab
Moderator
Dr. Azeem Latib
Dr. Azeem Latib
Dr. Matthew Summers
Dr. Stephen Worthley
Dr. Luca Testa
Dr. Amber Makani

Late-Breaking clinical science: LAAO

One-year outcomes with the Amulet™ 360 device for left atrial appendage closure: the VERITAS study

Date: Sunday, November 1

Time: 2:15–3:45PM PST

Location: Main Arena 5

Presenter: Dr. Dhanunjaya Lakkireddy

Add to calendar

CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and may not be commercially available.

Dr. Dhanunjaya Lakkireddy

Featured Clinical Research: Structural Heart

Thirty-day outcomes of a single-stage, transfemoral TMVR (Cephea™) in symptomatic mitral valve disease

Date: Sunday, November 1

Time: 2:57–3:18PM PST

Location: Innovation Theatre

Featured Expert: Dr. Torsten Vahl

Add to calendar

CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only.


Featured Clinical Research: Vascular

Drug-eluting resorbable scaffolds for long infrapopliteal lesions: insights from the Esprit™ BTK Post-Approval Study

Presented within Spotlight on endovascular: late breaking innovation in endovascular therapy

Date: Sunday, November 1

Presentation Time: 4:55PM PST

Q&A: 5:03PM PST

Location: Endovascular Arena 6

Presenter: Dr. Sahil A. Parikh

Dr. Sahil A. Parikh
Presenter

Monday, November 2

Visit Abbott in the Exhibit Hall to experience Abbott innovations through:

  • Live product demonstrations
  • Interactive hands-on learning opportunities
  • Case-based discussions with experts
  • Technology showcase across cardiovascular portfolio
  • Opportunities to connect with Abbott Product Experts

Abbott Booth # 4337


Hands-On Training: Training Pavilion

Ultreon™ 3.0 Software

Join this interactive KOL-led hands-on training session designed to enhance physician understanding of Ultreon™ 3.0 Software. Participants will review cases, learn and practice image interpretation, and explore how Ultreon™ 3.0 Software can support procedural planning, lesion assessment, and stent optimization.

Date: Monday, November 2

Time: 8:00–9:30AM and 10:00–11:30AM PST

Location: Upper Level | Sails Pavilion

Experts: Dr. Evan Shlofmitz, Dr. Allen Jeremias, Dr. Bassem Chehab, Dr. Dany Jacob

Dr. Evan Shlofmitz
Dr. Allen Jeremias
Dr. Bassem Chehab
Dr. Dany Jacob

Scientific Abstracts: Structural Heart

Five-year outcomes from the COAPT™ Post-Approval Study: insights from the TVT Registry and CMS claims database

Date: Monday, November 2

Time: 9:10–9:20AM PST

Location: Abstract Station 5

Featured Expert: Dr. Andrew Morse

Dr. Andrew Morse

Symposium: Structural Heart

Evidence to outcomes: optimizing treatment for tricuspid regurgitation

Date: Monday, November 2

Time: 12:30–1:45PM PST

Location: Structural Arena

Moderators: Dr. Anita Asgar

Featured Experts: Dr. Nadira Hamid, Dr. Wayne Batchelor, Dr. Ryan Kaple

Dr. Anita Asgar
Moderator
Dr. Nadira Hamid
Dr. Wayne Batchelor
Dr. Ryan Kaple

Symposium: Vascular

Beyond the force: the TECTONIC shift in imaging guided PCI and vessel preparation

Key discussion topics include:

  • The Ultreon™ 3.0 Advantage: Evidence Behind the Shift
  • The TECTONIC Effect: Clinical Insights and Case Experience
  • Efficiencies Enabled by Ultreon™ 3.0 Software
  • Optimizing Vessel Preparation with Imaging Insights
  • The Future of PCI

Date: Monday, November 2

Time: 12:45–1:45PM PST

Location: Room 6A

Moderator: Dr. Ethan Korngold

Speakers: Dr. Hayder Hashim, Dr. Eric Secemsky, Dr. Pratik Sandesara, Dr. Suhail Dohad

Dr. Ethan Korngold Moderator
Dr. Hayder Hashim
Dr. Eric Secemsky
Dr. Pratik Sandesara
Dr. Suhail Dohad

Scientific Abstracts: Structural Heart

Five-year outcomes of self-expanding intra-annular transcatheter heart valve in patients with severe aortic stenosis: an update from the Navitor™ IDE study

Date: Monday, November 2

Time: 3:30–3:40PM PST

Location: Abstract Station 7

Featured Expert: Dr. Clinton Kemp

Dr. Clinton Kemp

Tuesday, November 3

Scientific Abstracts: Structural Heart

Echocardiographic predictors of left ventricular outflow tract (LVOT) unsuitability and accuracy of neoLVOT area estimation in the Tendyne™ SUMMIT study

Date: Tuesday, November 3

Time: 9:10–9:20AM PST

Location: Abstract Station 5

Featured Expert: Dr. Gagan Singh

Dr. Gagan Singh

Scientific Abstracts: Structural Heart

1-year outcomes following TAVR with a self-expandable transcatheter aortic valve with intra-annular leaflet position: real-world data from the STS/ACC TVT Registry

Date: Tuesday, November 3

Time: 12:30–12:40PM PST

Location: Abstract Station 3

Featured Expert: Dr. Amber Makani

Dr. Amber Makani

Highlights at TCT 2026: TECTONIC CAD IVL IDE Study

The TECTONIC CAD IVL IDE Study is a prospective, single-arm, open-label, multi-center study to evaluate the safety and effectiveness of the SonicForce™ Coronary IVL System to treat severely calcified, stenotic de novo coronary arteries prior to stenting in 335 subjects at 40 sites in the US.

TECTONIC Highlights

Beyond the podium

Abbott is committed to advancing healthcare for the people impacted by cardiovascular and peripheral disease through the creation and delivery of life-changing technologies.

Explore how Abbott is meeting patient needs across coronary and peripheral interventions, from head to toe and from access to close.

Sign-up to get TCT post-show updates